Works matching IS 10685308 AND DT 2023 AND VI 34 AND IP 3
Results: 11
Paroxetine combined with oxycodone increases risk of respiratory depression.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 8, doi. 10.1002/pu.30991
- Publication type:
- Article
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 9, doi. 10.1002/pu.30992
- Publication type:
- Article
Gradual taper of antipsychotics safer in chronic schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 8, doi. 10.1002/pu.30990
- Publication type:
- Article
Mindfulness intervention noninferior to escitalopram for anxiety.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 6, doi. 10.1002/pu.30989
- Publication type:
- Article
Trials of cannabis‐based therapy show heightened placebo response.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 6, doi. 10.1002/pu.30988
- Publication type:
- Article
Treating stimulant use disorders: still searching for signals.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 7, doi. 10.1002/pu.30987
- By:
- Publication type:
- Article
Benzodiazepines for sleep disorders increase overdose risk in young people.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 4, doi. 10.1002/pu.30986
- Publication type:
- Article
Prolactin‐increasing antipsychotics associated with risk of low‐energy fractures.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 3, doi. 10.1002/pu.30985
- Publication type:
- Article
Once‐ versus multiple‐daily dosing of clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 2, doi. 10.1002/pu.30984
- By:
- Publication type:
- Article
ADHD medication use not associated with risk of cardiovascular disease.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 1, doi. 10.1002/pu.30983
- Publication type:
- Article
Lisdexamfetamine led to improved outcomes in patients with amphetamine use disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 1, doi. 10.1002/pu.30982
- Publication type:
- Article